Invetech, an innovator in new product development and custom automation for the biomedical, industrial and consumer markets, today announced that it has delivered the world's first production model 3D bio-printer to Organovo, developers of the proprietary NovoGen bioprinting technology. Organovo will supply the units to research institutions investigating human tissue repair and organ replacement.
Amazing bit of technology, they have adapted the 3d printing technology to work on human cells, allowing the building of biological parts to fit specification.
It isn't really production through, these are going out to health organizations developing this technology. At this point the only thing it can really do is build small simple structures and only using certain types of cells. But it can already make veins and arteries, and even just that would be useful. The potential if they can really get this working is nearly unlimited.
Jay